Scheiter, A.; Hierl, F.; Winkel, I.; Keil, F.; Klier-Richter, M.; Coulouarn, C.; Lüke, F.; Kandulski, A.; Evert, M.; Dietmaier, W.;
et al. Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities. J. Pers. Med. 2022, 12, 1270.
https://doi.org/10.3390/jpm12081270
AMA Style
Scheiter A, Hierl F, Winkel I, Keil F, Klier-Richter M, Coulouarn C, Lüke F, Kandulski A, Evert M, Dietmaier W,
et al. Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities. Journal of Personalized Medicine. 2022; 12(8):1270.
https://doi.org/10.3390/jpm12081270
Chicago/Turabian Style
Scheiter, Alexander, Frederik Hierl, Ingrid Winkel, Felix Keil, Margit Klier-Richter, Cédric Coulouarn, Florian Lüke, Arne Kandulski, Matthias Evert, Wolfgang Dietmaier,
and et al. 2022. "Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities" Journal of Personalized Medicine 12, no. 8: 1270.
https://doi.org/10.3390/jpm12081270
APA Style
Scheiter, A., Hierl, F., Winkel, I., Keil, F., Klier-Richter, M., Coulouarn, C., Lüke, F., Kandulski, A., Evert, M., Dietmaier, W., Calvisi, D. F., & Utpatel, K.
(2022). Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities. Journal of Personalized Medicine, 12(8), 1270.
https://doi.org/10.3390/jpm12081270